Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2014
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Robert J Motzer, Brian I Rini, David F McDermott, et al.
Family Medicine and Community Health
|
April 12, 2024
Storylines of family medicine VI: ways of being-in the office with patients
William B Ventres, Leslie A Stone, Lisa A LaVallee, et al.
European Urology
|
March 7, 2017
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
European Urology
|
January 8, 2018
Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71]
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Pediatric Transplantation
|
September 13, 2008
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning
Ian M Waxman, Olga Militano, Leah Baldinger, et al.
Bone Marrow Transplantation
|
June 12, 2012
The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients
J B Le Gall, M C Milone, I M Waxman, et al.
The New England Journal of Medicine
|
September 26, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
The New England Journal of Medicine
|
November 18, 2014
Nivolumab in previously untreated melanoma without BRAF mutation
Caroline Robert, Georgina V Long, Benjamin Brady, et al.
Science (New York, N.Y.)
|
April 23, 2026
An unrecognized mode of small particles in the lower stratosphere
Ming Lyu, Adam T Ahern, Gregory P Schill, et al.
Science Advances
|
May 13, 2026
Fate of isoprene peroxy radical constrains the urban photochemical regime
Michael A Robinson, Matthew M Coggon, Kelvin H Bates, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2014
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial
Robert J Motzer, Brian I Rini, David F McDermott, et al.
Family Medicine and Community Health
|
April 12, 2024
Storylines of family medicine VI: ways of being-in the office with patients
William B Ventres, Leslie A Stone, Lisa A LaVallee, et al.
European Urology
|
March 7, 2017
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
European Urology
|
January 8, 2018
Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71]
Bernard Escudier, Padmanee Sharma, David F McDermott, et al.
Pediatric Transplantation
|
September 13, 2008
Sequential administration of sargramostim and filgrastim in pediatric allogeneic stem cell transplantation recipients undergoing myeloablative conditioning
Ian M Waxman, Olga Militano, Leah Baldinger, et al.
Bone Marrow Transplantation
|
June 12, 2012
The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipients
J B Le Gall, M C Milone, I M Waxman, et al.
The New England Journal of Medicine
|
September 26, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J Motzer, Bernard Escudier, David F McDermott, et al.
The New England Journal of Medicine
|
November 18, 2014
Nivolumab in previously untreated melanoma without BRAF mutation
Caroline Robert, Georgina V Long, Benjamin Brady, et al.
Science (New York, N.Y.)
|
April 23, 2026
An unrecognized mode of small particles in the lower stratosphere
Ming Lyu, Adam T Ahern, Gregory P Schill, et al.
Science Advances
|
May 13, 2026
Fate of isoprene peroxy radical constrains the urban photochemical regime
Michael A Robinson, Matthew M Coggon, Kelvin H Bates, et al.
Page
of 15